- Home
- VRAX vs AEMD Comparison
VRAX vs AEMD Comparison
Compare VRAX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- AEMD
- Stock Information
- Founded
- VRAX 2013
- AEMD 1984
- Country
- VRAX United Kingdom
- AEMD United States
- Employees
- VRAX N/A
- AEMD N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AEMD Medical/Dental Instruments
- Sector
- VRAX Health Care
- AEMD Health Care
- Exchange
- VRAX Nasdaq
- AEMD Nasdaq
- Market Cap
- VRAX 5.9M
- AEMD 6.2M
- IPO Year
- VRAX 2022
- AEMD N/A
- Fundamental
- Price
- VRAX $1.09
- AEMD $0.37
- Analyst Decision
- VRAX Strong Buy
- AEMD Strong Buy
- Analyst Count
- VRAX 1
- AEMD 1
- Target Price
- VRAX $3.00
- AEMD $7.00
- AVG Volume (30 Days)
- VRAX 125.6K
- AEMD 139.9K
- Earning Date
- VRAX 02-05-2025
- AEMD 02-12-2025
- Dividend Yield
- VRAX N/A
- AEMD N/A
- EPS Growth
- VRAX N/A
- AEMD N/A
- EPS
- VRAX N/A
- AEMD N/A
- Revenue
- VRAX $84,872.00
- AEMD N/A
- Revenue This Year
- VRAX $5,169.18
- AEMD N/A
- Revenue Next Year
- VRAX $66.97
- AEMD N/A
- P/E Ratio
- VRAX N/A
- AEMD N/A
- Revenue Growth
- VRAX 7.03
- AEMD N/A
- 52 Week Low
- VRAX $0.60
- AEMD $0.24
- 52 Week High
- VRAX $9.00
- AEMD $1.79
- Technical
- Relative Strength Index (RSI)
- VRAX 32.51
- AEMD 37.58
- Support Level
- VRAX $1.10
- AEMD $0.35
- Resistance Level
- VRAX $1.35
- AEMD $0.60
- Average True Range (ATR)
- VRAX 0.11
- AEMD 0.03
- MACD
- VRAX 0.00
- AEMD 0.00
- Stochastic Oscillator
- VRAX 6.77
- AEMD 38.67
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.